TRVI icon

Trevi Therapeutics
TRVI

Overview Fund Activity

32 hedge funds and large institutions have $79.6M invested in Trevi Therapeutics in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
32
Holders Change
+9
Holders Change %
+39.13%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
12
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
1
NEA Management Company
Maryland
$32M
2
VA
2
VR Adviser
New York
$8.57M
3
RCMNY
3
Rubric Capital Management (New York)
New York
$5M
4
FFM
4
Fairmount Funds Management
Pennsylvania
$4.57M
5
ACM
5
Altium Capital Management
New York
$3.61M

Top Sellers

1
TGA
1
TPG GP A
Texas
$12.2M
2
Millennium Management
2
Millennium Management
New York
$186K
3
Marshall Wace
3
Marshall Wace
United Kingdom
$0
4
VF
4
Virtu Financial
New York
$0
5
Commonwealth Equity Services
5
Commonwealth Equity Services
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$13K +$8.58K +3,147 +194%
TRCT
27
Tower Research Capital (TRC)
New York
$11K -$15.9K -5,603 -59%
First Manhattan
28
First Manhattan
New York
$7K – – –
Citigroup
29
Citigroup
New York
$5K +$5K +1,700 New
CWM
30
Curi Wealth Management
North Carolina
$3K -$11.3K -3,746 -79%
AC
31
Armistice Capital
New York
$1.17K +$1.17K +416,000 New
Marshall Wace
32
Marshall Wace
United Kingdom
– -$52K -23,402 Closed
VF
33
Virtu Financial
New York
– -$44K -20,055 Closed
Commonwealth Equity Services
34
Commonwealth Equity Services
Massachusetts
– -$33K -15,000 Closed
Morgan Stanley
35
Morgan Stanley
New York
– -$1K -589 Closed
1
2